- Home
- SLG vs BLDEW Comparison
SLG vs BLDEW Comparison
Compare SLG & BLDEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLG
- BLDEW
- Stock Information
- Founded
- SLG 1980
- BLDEW 2014
- Country
- SLG United States
- BLDEW United States
- Employees
- SLG N/A
- BLDEW 281
- Industry
- SLG Real Estate Investment Trusts
- BLDEW Transportation Services
- Sector
- SLG Real Estate
- BLDEW Consumer Discretionary
- Exchange
- SLG Nasdaq
- BLDEW Nasdaq
- Market Cap
- SLG N/A
- BLDEW N/A
- IPO Year
- SLG 1997
- BLDEW N/A
- Fundamental
- Price
- SLG $57.98
- BLDEW $0.21
- Analyst Decision
- SLG Hold
- BLDEW
- Analyst Count
- SLG 16
- BLDEW 0
- Target Price
- SLG $69.81
- BLDEW N/A
- AVG Volume (30 Days)
- SLG 787.2K
- BLDEW 51.0K
- Earning Date
- SLG 04-16-2025
- BLDEW 03-13-2025
- Dividend Yield
- SLG 5.23%
- BLDEW N/A
- EPS Growth
- SLG N/A
- BLDEW N/A
- EPS
- SLG 0.08
- BLDEW N/A
- Revenue
- SLG $706,577,000.00
- BLDEW $241,814,000.00
- Revenue This Year
- SLG N/A
- BLDEW N/A
- Revenue Next Year
- SLG $2.06
- BLDEW N/A
- P/E Ratio
- SLG $737.96
- BLDEW N/A
- Revenue Growth
- SLG N/A
- BLDEW 12.04
- 52 Week Low
- SLG $47.22
- BLDEW $0.30
- 52 Week High
- SLG $82.81
- BLDEW $0.36
- Technical
- Relative Strength Index (RSI)
- SLG 41.92
- BLDEW N/A
- Support Level
- SLG $56.38
- BLDEW N/A
- Resistance Level
- SLG $59.70
- BLDEW N/A
- Average True Range (ATR)
- SLG 1.56
- BLDEW 0.00
- MACD
- SLG 0.21
- BLDEW 0.00
- Stochastic Oscillator
- SLG 60.68
- BLDEW 0.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.